Heritage Provider Network founded
Dr. Richard Merkin establishes the predecessor organization that grows into HPN — one of the country’s largest physician-owned integrated delivery systems.

Home / About / Philanthropy & Research
Philanthropy & ResearchFor more than four decades, Heritage and the Merkin family have invested in the institutions, researchers, and ideas that move medicine forward. Below: a timeline of milestones, the partner institutions involved, the prize challenges that have launched new research, and the education programs that build the next generation.
Meet the scholars & researchers we’ve funded →
See also: Profile of Dr. Richard Merkin →
From founding HPN in 1979 to this year’s Merkin Prize in Biomedical Technology, the through-line is a long-term investment in the people and institutions doing the most important work in medicine.
Dr. Richard Merkin establishes the predecessor organization that grows into HPN — one of the country’s largest physician-owned integrated delivery systems.

Community health outreach begins at High Desert Medical Group’s annual senior health fair — a model HPN groups still run today.
Dr. Merkin co-founds FasterCures (a center of the Milken Institute) to accelerate the development of treatments for prostate cancer, breast cancer, melanoma, and other diseases.

Long-running support of public charter schools across Los Angeles begins.

Sustained support for United Friends of the Children, providing services for foster youth in Los Angeles.

A free, public charter school delivering academic excellence and college-readiness for a traditionally underserved population in Los Angeles.

Founding member and sponsor of the Heritage Medical Research Institute Young Investigators Program at the Prostate Cancer Foundation.

HMRI is established to support translational medical research at leading academic institutions.
The Merkin Family Foundation begins its decades-long pattern of supporting biomedical technology, research, education, and the institutions doing that work.
The federation expands into the Antelope Valley and Santa Clarita Valley.
Direct scholarship funding for local students at Cal State LA begins.

The Richard Merkin Initiative is established at the Johns Hopkins Brain Sciences Institute, expanding the Hopkins relationship beyond the Peripheral Neuropathy Center.

Heritage joins the XPRIZE community, drawing inspiration from incentivized challenge prizes for healthcare innovation.

The Merkin Peripheral Neuropathy and Nerve Regeneration Center is funded at Johns Hopkins School of Medicine.

The Merkin Family Foundation pledges to fund the next generation of scientists at the Broad Institute. The fellowship would later include CRISPR pioneer Feng Zhang (2012/2013).

The Richard Merkin Foundation for Stem Cell Research is established at the Broad Institute of MIT and Harvard.

The Merkin-funded stem-cell program at the Broad helps reveal large intergenic non-coding RNAs (lincRNAs) — a new class of genes that regulate cellular function (Mitchell Guttman, John Rinn, and colleagues).

A global incentivized data-mining competition seeking a fundamental breakthrough in predicting future hospitalizations — aimed at the country’s estimated $40 billion in avoidable hospitalizations.
Joint-venture partnership with Fresenius Medical Care announced, expanding coordinated care for renal patients.
Launched in partnership with the Bipartisan Policy Center and The Advisory Board Company — a national contest to address the most daunting data problems in healthcare delivery.

Mid-competition leader of the Heritage Health Prize Challenge takes home an interim award at the Datapalooza announcement.
Dr. Richard Merkin is honored by the UCLA David Geffen School of Medicine for sustained contributions to biomedical research.

The Richard Merkin Foundation for Neural Regeneration is established at UCLA, alongside the Richard Merkin Fellowships in Nano-Neuroscience.

In partnership with the National Cancer Institute, a network-inference challenge for breast cancer announces its best performers.

Ongoing support of the Merkin Fellows Program funding two full-time researchers annually, plus sponsored research in Taiwan on ultrasound combination therapies for cancer.

HPN extends its coordinated-care model into the Phoenix metro and Maricopa County, growing the federation footprint beyond California.

The Merkin Initiative on Payment and Clinician Reform launches at Brookings, with Dr. Darshak Sanghavi as the inaugural Merkin Fellow.

Joint venture expanding member access to clinical services through Rite Aid’s retail health footprint.
Heritage launches a prize challenge in partnership with the NIH Office of Media Relations, leveraging cancer genomics data.

Permanently endowed Richard Merkin Fellowships in Emergency and Tropical Medicine at the Keck School of Medicine at USC.

The Richard N. Merkin M.D. Assistant Professorship Program funds early-career professors working on translational research at USC Keck.

The Merkin Family Foundation Fund for Regenerative Medicine is established at the Keck School of Medicine at USC.

The Heritage Research Institute for the Advancement of Medicine and Science begins funding professors across many scientific disciplines on translational research.

Scholarship funding established at the Schwarzman Scholars Program in Beijing — a one-year master’s program at Tsinghua University training the next generation of global leaders.

Scholarship funding for emerging leaders at Singularity University, working at the intersection of exponential technology and global challenges.

Dr. Merkin establishes a fund for two fully endowed professorships at City of Hope: the Heritage Professorship in Immunotherapy and the Heritage Professorship in Gene Therapy.
Funding for Nobel laureate Dr. Jennifer Doudna’s Innovative Genomics Institute, including CRISPR gene-editing research and disease-treatment programs for sickle cell.

David R. Liu — holder of the Richard Merkin Professorship at the Broad — develops base editing, the first method to make precise single-letter genome edits without cutting DNA.

Sponsored prize recognizing student innovation in robotics, science, and engineering.

Annual awards launched in NY, in partnership with Crain’s NY Business Custom Division, honoring innovative metropolitan healthcare leaders.
Sustained support for the National MS Society, advancing research and patient care.

HPN’s population-health certification program is established at USC.

A new clinic and urgent care center opens in Santa Clarita, expanding HPN’s coordinated-care footprint.
Dr. Merkin receives the inaugural Tommy Lasorda Leadership Award at the Milken Institute Global Gourmet Games benefit.

Heritage’s NY footprint takes shape through HealthCare Partners IPA — primary care and specialty coverage across Queens, Brooklyn, and Nassau.

Heritage Provider Network achieves the highest rankings from America’s Physician Groups Excellence Survey for the eleventh consecutive year.
Humana and HPN team up to offer a better patient experience for Humana Medicare Advantage members in California.

Heritage and Crain’s NY Business announce the judges for the 4th Annual Innovation Awards, reinforcing Heritage’s standing in NY-area healthcare innovation.

The Merkin Family Foundation funds the creation of a new Bachelor of Science in Health Service Coordination at WGU, plus multiple managed-care and population-health certificates.

The Merkin Institute for Transformative Technologies in Healthcare, led by Dr. David Liu (CRISPR base/prime editing pioneer), is established at the Broad Institute.

Primary sponsorship of the USC Schaeffer Center’s research programs on the future of medicine and hospitals in a post-pandemic world.

Direct support of the Longaker / Chan Laboratory at Stanford for promising research on the regrowth of human cartilage.

David R. Liu’s lab develops prime editing, a versatile genome-editing method capable of correcting most disease-causing mutations. Base and prime editing are now in more than 20 clinical trials.

The Richard N. Merkin Center for Pure and Applied Mathematics opens at Caltech.

A new annual prize created by the Merkin Family Foundation and administered by the Broad Institute of MIT and Harvard.

The Caltech Women in STEM (WiSTEM) program funds outreach, mentorship, and support for women in science, technology, engineering, and mathematics.

The Richard Merkin STEM Teacher / Mentor Visitation Program brings teachers and mentors to Caltech for sustained STEM-education engagements.

The Richard Merkin Travel Grants fund research-related travel for Caltech students and faculty across the institute’s scientific disciplines.

The Richard Merkin Startup Scholars Program supports Caltech researchers commercializing scientific work.

The Broad Institute of MIT and Harvard’s headquarters in Cambridge, MA is dedicated as the Richard N. Merkin building.

For developing automated technology for quickly synthesizing DNA — a foundational element of modern molecular biology.

The first CRISPR/Cas9-based medicine is approved for sickle-cell disease — built on genome-editing tools pioneered by Merkin Institute Fellow Feng Zhang, and CRISPR research the Merkin Family Foundation backed at both the Broad and UC Berkeley.
HPN achieves NCQA Elite status across all 9 affiliated medical groups in California.

Recognition for innovative healthcare initiatives benefiting all New Yorkers.

For T7 expression technology used to produce millions of doses of COVID-19 vaccines.

Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize for developing CAR T-cell therapy — now treating more than 45,000 cancer patients worldwide.

Graeme Clark, Erwin and Ingeborg Hochmair, Michael Merzenich, and Blake Wilson receive the 2026 Merkin Prize for the modern cochlear implant — used by more than a million people worldwide to access sound and spoken language.

Sixty-three milestones across four-plus decades. The timeline continues to grow as additional named programs and grants are documented from the Heritage Medical Research Institute and Merkin Family Foundation reports.
Through the Heritage Medical Research Institute, the Merkin Family Foundation, and direct giving, Heritage funds the work that turns laboratory discoveries into treatments.

The Broad Institute is based out of the Richard N. Merkin building in Cambridge, MA. Programs include the Richard Merkin Foundation for Stem Cell Research, the Merkin Institute Fellows Program (which notably funded Feng Zhang in 2012/2013), the Merkin Institute for Transformative Technologies in Healthcare led by Dr. David Liu, and the Merkin Prize in Biomedical Technology chaired by Nobel laureate Dr. Harold Varmus.

The Heritage Research Institute for the Advancement of Medicine and Science at Caltech funds professors working across many scientific disciplines on translational science. The Richard N. Merkin Center for Pure and Applied Mathematics brings together the Richard Merkin Professorships in Mathematics and is home to the American Institute of Math. Other Caltech programs: the Women in STEM (WiSTEM) program, the Richard Merkin STEM Teacher / Mentor Visitation Program, the Richard Merkin Travel Grants, and the Richard Merkin Startup Scholars Program.

The Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins, and the Richard Merkin Initiative at the Johns Hopkins Brain Sciences Institute.

The Merkin Family Foundation Fund for Regenerative Medicine, the permanently endowed Richard Merkin Fellowships in Emergency and Tropical Medicine, the Richard N. Merkin M.D. Assistant Professorship Program for young professors working on translational research, and primary sponsorship of the USC Schaeffer Center’s research on the future of medicine and hospitals in a post-pandemic world.

The Richard Merkin Foundation for Neural Regeneration, the Richard Merkin Fellowships in Nano-Neuroscience, and direct support for many translational R&D projects.

Funding for Nobel laureate Dr. Jennifer Doudna’s Integrative Genomics Institute, including CRISPR gene-editing research, delivery mechanisms for CRISPR edits, and specific disease-treatment programs for sickle cell.

Direct support of the Longaker / Chan Laboratory for promising research on the regrowth of human cartilage.
Two fully endowed professorships: the Heritage Professorship in Immunotherapy and the Heritage Professorship in Gene Therapy.

Ongoing support of the Merkin Fellows Program funding two full-time researchers annually, plus sponsored research in Taiwan on ultrasound combination therapies for cancer treatment.
Inspired in part by the X-Prize Foundation, Heritage has launched and sponsored prize challenges that mobilize global communities of problem solvers around the most important questions in healthcare.
A global incentivized data-mining competition seeking a fundamental breakthrough in predicting future hospitalizations — aimed at the estimated $40 billion in avoidable hospitalizations in the United States. Created an online community of problem solvers around predictive healthcare.
Honoring innovative NY metropolitan area healthcare leaders.
Sponsored prize recognizing student innovation in robotics, science, and engineering.
Prize challenge with the Institute of Medicine and the National Academy of Sciences.
Ongoing support and engagement with XPRIZE-style challenges in healthcare innovation.
Established 2022 in partnership with the Broad Institute of MIT and Harvard. Annual award to recognize novel technologies that have significantly improved human health.
Numerous additional prize challenges focused on breast cancer research and nanotechnology applications in medicine.
Beyond the major research initiatives, Heritage funds education, scholarships, and community institutions that build the next generation of clinicians, researchers, and leaders.
A free, public charter school delivering academic excellence and a college-readiness focus for a traditionally underserved population in Los Angeles.
Supporting public charter schools across Los Angeles.
The Merkin Initiative to Study Payment and Clinician Reform at Brookings in Washington, DC.
Founding member and sponsor. Accelerating the development of life-saving treatments and contributing to COVID-19 vaccine and treatment tracking.
Funding the creation of a new Bachelor of Science in Health Service Coordination and multiple certificates for specialization in managed care and population-health programs.
Scholarship funding at the Schwarzman Scholars Program in Beijing.
Scholarship funding for emerging leaders working at the intersection of technology and global challenges.
Direct scholarship funding for local students.
Founding member and sponsor of the Heritage Medical Research Institute Young Investigators Program.